Britain could have to wait longer for a coronavirus vaccine because of Brexit , experts have warned. Senior academics, writing in the Guardian, said Boris Johnson's decision to leave the European Medicines agency - which is in charge of monitoring the safety of medicines - could slow the process down.
Leaving the EU's regulatory regime means we will no longer have the benefit of "accelerated assessment" of new drugs, the authors argue.
The experts behind the article include Martin McKee of the London School of Hygiene and Tropical Medicine, and legal academics Anniek de Ruijter of Amsterdam Law School and Mark Flear of Queens University, Belfast.
Read more on mirror.co.uk